Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (33)

2018

  1. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain

    European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2011

  1. Efficacy of influenza a H1N1/2009 vaccine in hemodialysis and kidney transplant patients

    Clinical Journal of the American Society of Nephrology, Vol. 6, Núm. 9, pp. 2208-2214

2007

  1. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Núm. 7, pp. 485-490

  2. The Meropenem Yearly Susceptibility Test Information Collection antimicrobial susceptibility program in Spain: a 5-year analysis

    Diagnostic Microbiology and Infectious Disease, Vol. 57, Núm. 2, pp. 195-200

2006

  1. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 2, pp. 224-229

  2. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with prevenar in children with underlying chronic or recurrent lung diseases

    Clinical and Vaccine Immunology, Vol. 13, Núm. 6, pp. 665-670

2005

  1. New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 6, pp. 2237-2245

  2. Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51

  3. Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain

    Journal of Clinical Microbiology, Vol. 43, Núm. 3, pp. 1433-1436

2004

  1. Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

    Journal of Clinical Microbiology, Vol. 42, Núm. 10, pp. 4853-4855

  2. Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 4, pp. 620-625

2003

  1. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 967-973

  2. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones

    International Journal of Antimicrobial Agents

2000

  1. Seroepidemiology of Bordetella pertussis infections in the Spanish population: A cross-sectional study

    Vaccine, Vol. 18, Núm. 21, pp. 2173-2176

1999

  1. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the spanish general population?

    Journal of Medical Virology, Vol. 59, Núm. 2, pp. 194-197

  2. Whole cell lysate enzyme immunoassays vs. Recombinant glycoprotein G2- based immunoassays for HSV-2 seroprevalence studies

    Journal of Medical Virology, Vol. 59, Núm. 4, pp. 502-506

1998

  1. Situación epidemiológica actual y resistencia de los patógenos respiratorios en Espan̄a

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 44-51

1997

  1. Double blind clinical trial comparing 5 days of dirythromycin versus 7 days of diacetymidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 15, Núm. 7, pp. 357-360

  2. Penetracion de meropenem en bacilos gramnegativos. Diferencias de actividad con imipenem

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 15, Núm. SUPPL. 1, pp. 14-19